Form 4: Liquidia CBO Sells Shares After Option Exercise
Insider Transaction Report
Liquidia Corp's Chief Business Officer, Jason Adair, exercised stock options and subsequently sold 35,656 shares of common stock for approximately $1.07 million.
Summary
- Jason Adair, Chief Business Officer of Liquidia Corp (LQDA), reported transactions on November 18, 2025.
- Adair exercised incentive and non-qualified stock options to acquire a total of 35,656 shares of common stock at an exercise price of $5.89 per share.
- Immediately following the exercise, Adair sold all 35,656 shares at a volume-weighted average price of $30.0289 per share.
- The total proceeds from the sale amounted to approximately $1,070,600.
- These transactions were conducted pursuant to a Rule 10b5-1 plan adopted on May 29, 2025.
- Following these transactions, Adair beneficially owns 174,998 shares of common stock, which includes unvested restricted stock units and shares acquired under the Employee Stock Purchase Plan.
Sentiment
Score: 5
Explanation: Neutral. This is a routine insider transaction report, not indicative of positive or negative company performance. The sale was pre-planned under a 10b5-1 plan, which mitigates negative sentiment often associated with insider sales.
Positives
- The transactions were executed under a pre-arranged Rule 10b5-1 plan, indicating a planned sale rather than an immediate reaction to new information.
- The sale price of $30.0289 per share is significantly higher than the option exercise price of $5.89, indicating a substantial gain for the officer.
Negatives
- An insider sale, even if pre-planned, can sometimes be perceived negatively by the market, as it reduces the officer's direct equity stake.
Future Outlook
This Form 4 filing does not contain any forward-looking statements or guidance regarding the company's future performance or strategic direction. It solely reports an insider's past transactions.
Management Comments
- The reporting person undertakes to provide full information regarding the number of shares sold at each separate price within the range of $30.00 to $30.15 upon request.
Industry Context
This insider transaction is a routine disclosure for publicly traded companies and does not inherently reflect broader industry trends. Insider sales, especially those pre-planned under Rule 10b5-1, are common for executive compensation and personal financial management.
Comparison to Industry Standards
- Insider transactions like this are standard practice across all industries for executives managing their equity compensation.
- The use of a Rule 10b5-1 plan aligns with best practices for avoiding accusations of trading on material non-public information.
- No specific comparable companies or projects are relevant for this type of individual transaction report.
Stakeholder Impact
- Shareholders: The sale by a Chief Business Officer could be interpreted in various ways, but the 10b5-1 plan suggests it is not based on new material information. It slightly reduces insider ownership.
Next Steps
- No specific future actions or milestones for the company are mentioned in this insider transaction report.
Key Dates
| Date | Description |
|---|---|
| 01/05/2017 | Option vesting began (25% vested). |
| 01/05/2020 | Options fully vested. |
| 07/06/2023 | Grant date for 25,000 restricted stock units. |
| 01/11/2024 | Grant date for 39,588 restricted stock units. |
| 01/11/2025 | Grant date for 61,895 restricted stock units. |
| 05/29/2025 | Date Rule 10b5-1 plan was adopted by the Reporting Person. |
| 11/18/2025 | Date of stock option exercise and subsequent sale of common stock. |
| 11/20/2025 | Signature date of the Form 4 filing. |
| 01/05/2026 | Expiration date of the exercised stock options. |
Recommendation
holdThis Form 4 filing details a routine, pre-planned insider transaction by the Chief Business Officer, involving the exercise of stock options and subsequent sale of shares. Such transactions are common for executive compensation and personal financial planning, especially when executed under a Rule 10b5-1 plan, which mitigates concerns about trading on non-public information. The filing does not provide new information about the company's operational performance, financial health, or strategic outlook that would warrant a change in investment recommendation. Therefore, a 'hold' recommendation is appropriate as this filing alone does not present a compelling reason to buy or sell the stock.
Keywords
Liquidia Corp, LQDA, Form 4, Insider Trading, Stock Option Exercise, Share Sale, Chief Business Officer, Jason Adair, Rule 10b5-1
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.